Zobrazeno 1 - 8
of 8
pro vyhledávání: '"M M Beraya"'
Autor:
D A Tsaregorodtsev, A V Sokolov, S S Vasyukov, M M Beraya, I L Ilyich, I A Khamnagadaev, A V Nedostup
Publikováno v:
Терапевтический архив, Vol 89, Iss 12-2, Pp 157-164 (2017)
Objective. To determine criteria for choosing management tactics in patients with ventricular arrhythmias (VA) in the absence of structural heart disease from the point of view of physicians and patients in clinical practice and to compare the immedi
Externí odkaz:
https://doaj.org/article/509aeb615a9a40639cc058297929b2e4
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 19, Iss 2, Pp 151-159 (2023)
Aim. To study the efficacy of class IC arrhythmic drugs (AAD) and catheter ablation (CA) for paroxysmal form of atrial fibrillation (AF) in patients with without structural heart disease.Material and methods. The study included 122 patients (44 men,
Externí odkaz:
https://doaj.org/article/b93f048e73b74f8084852e3ba2fdd19d
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 21, Iss 6 (2022)
Aim. To study the advantages of using a portable electrocardiographic (ECG) monitor in outpatients with paroxysmal atrial fibrillation (AF).Material and methods. We examined 88 patients (26 men, 62 women, mean age, 63 [57;68] years) with paroxysmal A
Externí odkaz:
https://doaj.org/article/81b2c3fdaffa496e9e5c371f6959d9d8
Publikováno v:
Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 17, Iss 6, Pp 860-866 (2022)
Aim. To study the psychosomatic relationships and quality of life (QOL) of patients with paroxysmal supraventricular tachycardia (SVT) depending on the presence or absence of panic attacks (PA) in comparison with patients with heartbeat against the b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d27dfa1f24301e80455626081b78ed0f
https://doi.org/10.20996/1819-6446-2021-12-09
https://doi.org/10.20996/1819-6446-2021-12-09
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 1, Pp 45-47 (2007)
In total, 62patients with mild to moderate arterial hypertension underwent echocardiography and Doppler cardiography. For 12 weeks, all participants received spirapril, 6 mg/d. Spirapril therapy was associated with reduced left ventricular hypertroph
Externí odkaz:
https://doaj.org/article/8acd6a1d39b04b13b39853fa2525c06c
Autor:
Nedostup Av, A. V. Sokolov, M. M. Beraya, I A Khamnagadaev, D A Tsaregorodtsev, I L Ilyich, S. S. Vasyukov
Publikováno v:
Терапевтический архив, Vol 89, Iss 12-2, Pp 157-164 (2017)
To determine criteria for choosing management tactics in patients with ventricular arrhythmias (VA) in the absence of structural heart disease from the point of view of physicians and patients in clinical practice and to compare the immediate results
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82b6d22b966a77f1b8818244c06504e1
https://ter-arkhiv.ru/0040-3660/article/view/32337
https://ter-arkhiv.ru/0040-3660/article/view/32337
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 5, Iss 8, Pp 22-28 (1970)
Aim. То study 12-week spirapril (Quadropril®) therapy effectiveness in patients with mild to moderate arterial hypertension (АП). Material and metliods. For 12 weeks, 62 patients with mild to moderate АП received spirapril (6 mg/d), with diure
Externí odkaz:
https://doaj.org/article/9cf2989c7b894f8597469ce57a7334b1
Publikováno v:
Kardiologiya i serdechno-sosudistaya khirurgiya. 9:76
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::431e134ab99d81edc5802f3ca85e3fd0
https://doi.org/10.17116/kardio20169176-81
https://doi.org/10.17116/kardio20169176-81